Jayex Technology (ASX: JTL) Share Price and News
Price
–
Movement
– ( )
(20 mins delayed)
52 Week Range
– - –
1 Year Return
Jayex Technology Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
–
Day Change
– ( )
52 Week Range
– - –
Yesterday's Close
–
Today's Open
–
Days Range
– - –
Volume
–
Avg. Volume (1 month)
–
Turnover
–
Jayex Technology (ASX: JTL)
Latest News
No posts found.
JTL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|
About Jayex Technology
Jayex Technology Ltd. is an integrated healthcare services delivery platform. It provides healthcare service technologies and integrated dispensing automation systems. The company was founded in 1978 and is headquartered in Milton, Australia.
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Michael Denis Boyd | Non-Executive ChairmanNon-Executive Director | Oct 2022 |
Mr. Boyd has been involved in the creation of new enterprises, both in the private and public sectors, for over 27 years. Mr. Boyd has been in developing and growing new projects in areas including healthcare, telecommunications and finance. He started Foundation Healthcare, growing it to over 800 healthcare professionals before it was acquired by Sonic. He was also a founding partner of Iridium Satellite bringing it out from bankruptcy to now a NASDAQ listed company.
|
| Mr William Denis Boyd | Non-Executive Director | Jun 2024 |
Mr Boyd has a history in the provision of healthcare services in Australia over the past forty years
|
| Mr Brian Renwick | Non-Executive Director | Jul 2009 |
Mr. Renwick is experienced across the pharmaceutical and healthcare sector in Australia. His involvement with sector commenced in finance roles that led into commercial analysis, marketing and sales. From this experience in the manufacturing end of the supply chain he moved into the wholesaling with various business development roles in retail and hospital pharmacy. Mr Renwick's roles broadened into commercial and business development including as general manager for a corporate pharmacy business. He has completed two Business Development roles within the CSL Limited group. With his knowledge and experience across the healthcare sector, Brian has provided consulting advice to Jayex since 2006 and is a member of the team.
|
| Ms Melanie Jaye Leydin | Company Secretary | Aug 2015 |
-
|
| Mr Robert Hadley | Chief Executive Officer | Oct 2022 |
-
|
| Robert Hadley | Chief Executive Officer |
-
|
|
| Melanie Jaye Leydin | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Lirho Pty Ltd < Boyd 4 A/C > | 103,883,880 | 36.93% |
| Vector London Ltd | 19,003,378 | 6.76% |
| Mary Kathleen Simcox | 17,500,000 | 6.22% |
| Donovan Products Pty Ltd < Family Account > | 12,035,943 | 4.28% |
| Turbine Capital Limited | 8,800,000 | 3.13% |
| Covenant Holding (Wa) Pty Ltd | 7,000,000 | 2.49% |
| Citicorp Nominees Pty Limited | 6,455,163 | 2.29% |
| Bnp Paribas Nominees Pty Ltd < Ib Au Noms Retailclient > | 5,990,327 | 2.13% |
| Mr Joel David Webb | 5,500,000 | 1.96% |
| Mrs Vanessa Faye Connor | 5,174,808 | 1.84% |
| Mr Dean Henry Cleary < The Clearway Investment A/C > | 4,140,000 | 1.47% |
| Amg Corporate Pty Ltd < The Amg Super Fund A/C > | 3,000,000 | 1.07% |
| Mr David Ariti | 2,839,777 | 1.01% |
| Mr Michael Raeburn Connor | 2,445,079 | 0.87% |
| Mr Jeremy Ruben & Mrs Vanessa Ruben < Jvr Super Fund A/C > | 2,008,067 | 0.71% |
| Mr Stephen John Hart | 2,000,000 | 0.71% |
| Mr Yuliang Fan | 2,000,000 | 0.71% |
| Ms Chunyan Niu | 2,000,000 | 0.71% |
| Super Msj Pty Ltd < Msj Super Fund A/C > | 2,000,000 | 0.71% |
| Mr Samuel Gershon Jacobs & Mrs Sarita Devi Jacobs & Miss Manekha Bridgette Jacobs | 1,977,083 | 0.70% |